Nippon Life Global Investors Americas, Inc. Biomarin Pharmaceutical Inc Transaction History

Nippon Life Global Investors Americas, Inc.

$2.3 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $18.3 Million - $20.3 Million	-215,210 Reduced 87.03%	32,070 $2.84 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $2.18 Million - $2.53 Million	-25,180 Reduced 9.24%	247,280 $21.4 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $1.22 Million - $1.64 Million	-13,950 Reduced 4.87%	272,460 $26.5 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $825,486 - $1.11 Million	10,200 Added 3.69%	286,410 $29.6 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $4.72 Million - $5.57 Million	57,430 Added 26.25%	276,210 $23.4 Million
Q1 2022 May 11, 2022	SELL	$74.28 - $92.69 $788,853 - $984,367	-10,620 Reduced 4.63%	218,780 $16.9 Million
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $97,539 - $124,399	-1,360 Reduced 0.59%	229,400 $20.3 Million
Q3 2021 Nov 05, 2021	BUY	$74.77 - $85.47 $1.31 Million - $1.5 Million	17,580 Added 8.25%	230,760 $17.8 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $655,426 - $735,977	-8,680 Reduced 3.91%	213,180 $17.8 Million
Q1 2021 May 07, 2021	BUY	$74.73 - $90.69 $570,937 - $692,871	7,640 Added 3.57%	221,860 $16.8 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $518,182 - $944,726	7,210 Added 3.48%	214,220 $16.3 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $2.89 Million - $4.52 Million	-36,370 Reduced 14.94%	207,010 $25.5 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $17.4 Million - $23.6 Million	243,380 New	243,380 $20.6 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account